Download MendeleyDiscovery of aminoheterocycles as a novel beta-secretase inhibitor class: pH dependence on binding activity part 1.
Stachel, S.J., Coburn, C.A., Rush, D., Jones, K.L., Zhu, H., Rajapakse, H., Graham, S.L., Simon, A., Katharine Holloway, M., Allison, T.J., Munshi, S.K., Espeseth, A.S., Zuck, P., Colussi, D., Wolfe, A., Pietrak, B.L., Lai, M.T., Vacca, J.P.(2009) Bioorg Med Chem Lett 19: 2977-2980
- PubMed: 19409780
- DOI: https://doi.org/10.1016/j.bmcl.2009.04.033
- Primary Citation of Related Structures:
3H0B - PubMed Abstract:
We have developed a novel series of heteroaromatic BACE-1 inhibitors. These inhibitors interact with the enzyme in a unique fashion that allows for potent binding in a non-traditional paradigm. In addition to the elucidation of their binding profile, we have discovered a pH dependent effect on the binding affinity as a result of the intrinsic pK(a) of these inhibitors and the pH of the BACE-1 enzyme binding assay.
Organizational Affiliation:
Department of Medicinal Chemistry, Merck Research Laboratories, Merck & Co, West Point, PA 19486, USA. shawn_stachel@merck.com
